Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-naïve and treatment-experienced people with HIV: 12-month virologic effectiveness and safety outcomes in the BICSTaR Japan cohort - Yoshiyuki Yokomaku; Katsuji Teruya; Dai Watanabe; Tomoyuki Endo; Rumi Minami; Nao Taguchi; Tali Cassidy; Andrea Marongiu; David Thorpe; Takuma Shirasaka; Shinichi Oka (PLoS ONE, 2025)